Global Gonorrhea Therapeutics Market Research Report 2023

Publisher Name :
Date: 07-Feb-2023
No. of pages: 86
Inquire Before Buying

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.

Highlights

The global Gonorrhea Therapeutics market was valued at US$ 1128.3 million in 2022 and is anticipated to reach US$ 1427.7 million by 2029, witnessing a CAGR of 4.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gonorrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonorrhea Therapeutics.

The Gonorrhea Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gonorrhea Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gonorrhea Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Bharat Pharmaceuticals

- GlaxoSmithKline

- Merck

- Pfizer

- Alopexx Pharmaceuticals

- AstraZeneca

- Debiopharm Group

- Melinta Therapeutics

Segment by Type

- Monotherapy

- Dual Therapy

Segment by Application

- Clinics

- Hospitals

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gonorrhea Therapeutics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Gonorrhea Therapeutics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monotherapy
1.2.3 Dual Therapy
1.3 Market by Application
1.3.1 Global Gonorrhea Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Therapeutics Market Perspective (2018-2029)
2.2 Gonorrhea Therapeutics Growth Trends by Region
2.2.1 Global Gonorrhea Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gonorrhea Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Gonorrhea Therapeutics Market Dynamics
2.3.1 Gonorrhea Therapeutics Industry Trends
2.3.2 Gonorrhea Therapeutics Market Drivers
2.3.3 Gonorrhea Therapeutics Market Challenges
2.3.4 Gonorrhea Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Therapeutics Players by Revenue
3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2022
3.5 Gonorrhea Therapeutics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Therapeutics Product Solution and Service
3.7 Date of Enter into Gonorrhea Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gonorrhea Therapeutics Breakdown Data by Type
4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2024-2029)
5 Gonorrhea Therapeutics Breakdown Data by Application
5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gonorrhea Therapeutics Market Size (2018-2029)
6.2 North America Gonorrhea Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gonorrhea Therapeutics Market Size by Country (2018-2023)
6.4 North America Gonorrhea Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gonorrhea Therapeutics Market Size (2018-2029)
7.2 Europe Gonorrhea Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gonorrhea Therapeutics Market Size by Country (2018-2023)
7.4 Europe Gonorrhea Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Gonorrhea Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gonorrhea Therapeutics Market Size (2018-2029)
9.2 Latin America Gonorrhea Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gonorrhea Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Gonorrhea Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Gonorrhea Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bharat Pharmaceuticals
11.1.1 Bharat Pharmaceuticals Company Detail
11.1.2 Bharat Pharmaceuticals Business Overview
11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.1.5 Bharat Pharmaceuticals Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Gonorrhea Therapeutics Introduction
11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gonorrhea Therapeutics Introduction
11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Alopexx Pharmaceuticals
11.5.1 Alopexx Pharmaceuticals Company Detail
11.5.2 Alopexx Pharmaceuticals Business Overview
11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.5.5 Alopexx Pharmaceuticals Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Debiopharm Group
11.7.1 Debiopharm Group Company Detail
11.7.2 Debiopharm Group Business Overview
11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.7.5 Debiopharm Group Recent Development
11.8 Melinta Therapeutics
11.8.1 Melinta Therapeutics Company Detail
11.8.2 Melinta Therapeutics Business Overview
11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.8.5 Melinta Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monotherapy
Table 3. Key Players of Dual Therapy
Table 4. Global Gonorrhea Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gonorrhea Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gonorrhea Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gonorrhea Therapeutics Market Share by Region (2018-2023)
Table 8. Global Gonorrhea Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gonorrhea Therapeutics Market Share by Region (2024-2029)
Table 10. Gonorrhea Therapeutics Market Trends
Table 11. Gonorrhea Therapeutics Market Drivers
Table 12. Gonorrhea Therapeutics Market Challenges
Table 13. Gonorrhea Therapeutics Market Restraints
Table 14. Global Gonorrhea Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gonorrhea Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2022)
Table 17. Ranking of Global Top Gonorrhea Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gonorrhea Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gonorrhea Therapeutics Product Solution and Service
Table 21. Date of Enter into Gonorrhea Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gonorrhea Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Gonorrhea Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gonorrhea Therapeutics Revenue Market Share by Type (2024-2029)
Table 27. Global Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gonorrhea Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Gonorrhea Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gonorrhea Therapeutics Revenue Market Share by Application (2024-2029)
Table 31. North America Gonorrhea Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gonorrhea Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gonorrhea Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gonorrhea Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gonorrhea Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Bharat Pharmaceuticals Company Detail
Table 47. Bharat Pharmaceuticals Business Overview
Table 48. Bharat Pharmaceuticals Gonorrhea Therapeutics Product
Table 49. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Bharat Pharmaceuticals Recent Development
Table 51. GlaxoSmithKline Company Detail
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Gonorrhea Therapeutics Product
Table 54. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Gonorrhea Therapeutics Product
Table 59. Merck Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Gonorrhea Therapeutics Product
Table 64. Pfizer Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Alopexx Pharmaceuticals Company Detail
Table 67. Alopexx Pharmaceuticals Business Overview
Table 68. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product
Table 69. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Alopexx Pharmaceuticals Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Gonorrhea Therapeutics Product
Table 74. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Debiopharm Group Company Detail
Table 77. Debiopharm Group Business Overview
Table 78. Debiopharm Group Gonorrhea Therapeutics Product
Table 79. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Debiopharm Group Recent Development
Table 81. Melinta Therapeutics Company Detail
Table 82. Melinta Therapeutics Business Overview
Table 83. Melinta Therapeutics Gonorrhea Therapeutics Product
Table 84. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Melinta Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gonorrhea Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Monotherapy Features
Figure 4. Dual Therapy Features
Figure 5. Global Gonorrhea Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gonorrhea Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Gonorrhea Therapeutics Report Years Considered
Figure 11. Global Gonorrhea Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gonorrhea Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gonorrhea Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Gonorrhea Therapeutics Market Share by Players in 2022
Figure 15. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2022
Figure 17. North America Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 19. United States Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gonorrhea Therapeutics Market Share by Region (2018-2029)
Figure 31. China Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 49. Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 51. Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 52. Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Sexually Transmitted Diseases Testing Professional Survey Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Diseases Testing Market Research Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (STD) Testing Market Status and Outlook 2023-2028
    Published: 23-Nov-2023        Price: US 3160 Onwards        Pages: 102
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (Std) Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Sexually Transmitted Disease (Std) Testing market: According to our latest research, the global Sexually Transmitted Disease (Std) Testing market looks promising in the next 5 years. As of 2022, the global Sexually Transmitted Disease (Std) Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and pr......
  • Global Gonorrhea Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gonorrhea Therapeutics market: According to our latest research, the global Gonorrhea Therapeutics market looks promising in the next 5 years. As of 2022, the global Gonorrhea Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhea. It tends to infect the urethra......
  • Global Gonorrhea Therapeutics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 89
    Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospec......
  • Global Sexually Transmitted Disease (STD) Testing Market Insights, Forecast to 2029
    Published: 01-Jun-2023        Price: US 4900 Onwards        Pages: 92
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Testing Market The global Sexually Transmitted Disease (STD) Testing market is projected to grow from US$ 225.3 million in 2023 to US$ 338.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period. The need for tests that eliminate ......
  • Global Sexually Transmitted Disease (STD) Testing Market Research Report 2023
    Published: 05-May-2023        Price: US 2900 Onwards        Pages: 89
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Highlights The global Sexually Transmitted Disease (STD) Testing market was valued at US$ 225.3 million in 2022 and is anticipated to reach US$ 338.1 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The need ......
  • Global Gonorrhea Therapeutics Market Status and Outlook 2023-2028
    Published: 24-Apr-2023        Price: US 3160 Onwards        Pages: 104
    Neisseria gonorrhoeae infection can manifest as a variety of symptoms, which can affect the genitourinary system, anorectum, pharynx, and conjunctival area. Severe cases can lead to disseminated gonococcal infection, endocarditis and meningitis; in women, it is pelvic inflammatory disease (PID). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs